BHST (bioharvest.com) Market Value to Book Value Ratio

Official company branding of BioHarvest Sciences, Inc. (BHST)

BioHarvest Sciences (BHST) is developing a cutting-edge plant cell biofarming direction. This chart of stock quotes on the GURU.Markets platform correlates with success in attracting top scientists through the R&D environment and stock options, with the metric standing at 1.96. The business relies on proprietary biomass cultivation methods in reactors, creating insurmountable patent barriers. Simultaneously, BioHarvest Sciences (BHST) minimizes its ecological footprint by radically reducing water and land resource consumption.

BHST BioHarvest Sciences Inc: Market Value to Book Value in the range 11/13/2024 - 10/28/2026
Original product of BioHarvest

This ratio reflects the market value premium over net assets, measuring the level of investor confidence in the future growth of BioHarvest Sciences (BHST) relative to its current balance sheet. By analyzing the market capitalization to book value ratio, a professional assesses whether the premium paid for the intellectual potential of BioHarvest Sciences in the field of cellular metabolite synthesis and its strategic alliances with nutraceutical manufacturers is justified.

Main competitors

HLN - Market Cap to Net Assets Ratio|KVUE (kenvue.com) - Market Cap to Book Value Multiple|Market Value to Book Value Ratio Verona Pharma VRNA|Market Capitalization to Net Assets Jyong Biotech Limited|Ligand Pharma (LGND) - Market Capitalization to Book Value Ratio|Market Value to Book Value Amneal Corp (AMRX)|Market Capitalization to Book Value Ratio PRGO (Perrigo Company plc)|alvotech.com - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Liquidia (LQDA)|GLPG: Market Value to Book Value|ANIP (ANI Pharma) - Market Value to Book Value Ratio|Afrezza (MNKD) - Market Cap to Net Assets Ratio|AMPH (Amphastar Pharmaceuticals) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio pacira.com (PCRX)|ARS Pharmaceuticals, Inc. (SPRY) - Market Cap to Net Assets Ratio|Market Value to Book Value TBPH (Theravance Biopharma Inc)|AQST: Market Value to Book Value Ratio|SCPH - Market-to-Book Ratio|Market Cap to Net Assets Ratio Tectonic TECX|TNXP - Market Cap to Book Value Multiple|Market Capitalization to Book Value Ratio sxtchina.com SXTC|Eupraxia Pharmaceuticals Inc. (EPRX) - Market Value to Book Value|Market Capitalization to Book Value Ratio EXOZ (Invizyne Technologies, Inc.)|Market-to-Book Ratio ORMP|Entera Bio Ltd. (ENTX) - Market Value to Book Value Ratio|Market Value to Book Value ipatherapeutics.com (HYFT)|Market Capitalization to Book Value Ratio ABVC BioPharma, Inc. ABVC|Market Value to Book Value Ratio Cumberland Pharmaceuticals Inc CPIX|Market Capitalization to Book Value Ratio QNTM (Quantum BioPharma Limited)|FGEN: Market Capitalization to Book Value|Market Value to Book Value Ratio TELO|Rani Therapeutics Holdings, Inc. (RANI) - Market-to-Book Ratio|SNYR - Market Capitalization to Book Value Ratio|Market Value to Book Value Rallybio Corp.|Market Capitalization to Book Value Ratio LEXX|Market Capitalization to Book Value Ratio PULM (Pulmatrix Corporation)|Market Value to Book Value Ratio Pheton Holdings|APM - Market Value to Book Value|LYRA - Market Cap to Net Assets Ratio|IBO - Market Value to Book Value Ratio|Market Capitalization to Book Value Ratio TNFA|YCBD (cbdMD) - Market-to-Book Ratio|PRFX: Market Value to Book Value Ratio|Market Capitalization to Book Value Auris Medical (CYTO)|Market Cap to Net Assets Ratio Lipella Pharmaceuticals, Inc.|Market Cap to Book Value Multiple OptiNose Inc OPTN|Market Cap to Net Assets Ratio Pieris|Procaps Group Corp - Market Value to Book Value|Market Value to Book Value Ratio PTPI (Petros Pharmaceuticals)|QLI - Market Capitalization to Book Value|SLRN (ACELYRIN) - Market Capitalization to Book Value Ratio|TFF Pharmaceuticals Inc. (TFFP) - Market Cap to Net Assets Ratio